A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2004
12/28/2004	US6835724 Corticoid 17,21-dicarboxylic esters and corticosteroid 17-carboxylic ester 21-carbonic esters, processes for their preparation and pharmaceuticals containing these compounds
12/28/2004	US6835723 Purification including dissolving in boiled solvent, cooling solvent and dissolved product below ambient temperature, purification
12/28/2004	US6835722 Pharmaceutical compositions and preparations for treatment of metabolic bone disease
12/28/2004	US6835721 Phosphate or ammonium compounds that function as immunological adjuvants when co-administered with antigens such as vaccines for bacterial and viral diseases
12/28/2004	US6835719 A liquid suspension comprising sulfur and pyrethrum as pesticides, insecticides; no phytotoxicity
12/28/2004	US6835717 Such as human immunodeficiency virus (HIV), herpes virus, Chlamydia spp., a Trichomona spp., or a Candida spp.
12/28/2004	US6835716 Bactericides, antiprotozoa agents
12/28/2004	US6835715 Mammalian dihydroouabain-like factor and therapeutic compositions
12/28/2004	US6835714 Heterocyclic compounds, intermediates thereof and elastase inhibitors
12/28/2004	US6835546 Drosophila G protein coupled receptors, nucleic acids, and methods related to the same
12/28/2004	US6835536 Therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, in the treatment of microorganism-caused infections, which infections may be systemic, such as a
12/28/2004	US6835401 Method of treating diseases caused by over-production of free-radicals
12/28/2004	US6835396 Energizing a multiphase system having an organic phase containing a poorly water soluble compound, e.g. drug, and an aqueous phase to form a fine dispersion; freeze drying; particularly for intravenous injection
12/28/2004	US6835393 Enhanced transport using membrane disruptive agents
12/28/2004	US6835392 Dual enhancer composition for topical and transdermal drug delivery
12/28/2004	US6835388 Mixing a compound which acts as a local anesthetic with physiological salt; placing formulation in a catheter; administering formulation into uterine cavity of woman with a catheter; pertubating the formulation into peritoneal cavity
12/28/2004	US6835372 Mixtures of di-(tri)peptides and drugs such as cyclosporin used as aerosols; drug delivery
12/28/2004	US6835370 Diagnosis and treatment of malignant neoplasms
12/28/2004	US6835194 Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
12/28/2004	CA2331297C Hygromycin a derivatives
12/28/2004	CA2281426C Substituted indole compounds as anti-inflammatory and analgesic agents
12/28/2004	CA2268922C Methods of treating or preventing cardiac arrhythmia
12/28/2004	CA2245483C Fat based food products comprising sterols
12/28/2004	CA2240329C Improved delivery of multiple doses of medications
12/28/2004	CA2226039C Pyridylfuran and pyridylthiophene compounds
12/28/2004	CA2128103C Formulation and use of carotenoids in treatment of cancer
12/28/2004	CA2126072C Tri-substituted phenyl derivatives and processes for their preparation
12/28/2004	CA2120709C Enzyme-orthokeratology
12/28/2004	CA2117199C Method for the treatment of the complications and pathology of diabetes
12/28/2004	CA2105923C 7-isoindolinyl-quinolone derivatives and 7-isoindolinyl-naphthyridone derivatives
12/27/2004	CA2451268A1 Alpha2delta ligands for the treatment of fibromyalgia and other disorders
12/25/2004	CA2472294A1 New derivatives of benzo[a]pyrano[3,2-h]acridin-7-one, a process for their preparation and pharmaceutical compounds containing them
12/25/2004	CA2433246A1 Process for recovering value-added products from pulping soap
12/23/2004	WO2004111652A1 Use of prion conversion modulating agents
12/23/2004	WO2004111253A2 Polyvalent metal-substituted starch products
12/23/2004	WO2004111199A2 Systems and methods for treating human inflammatory and proliferative diseases and wounds, with fatty acid metabolism inhibitors and/or glycolytic inhibitors
12/23/2004	WO2004111071A1 5'-aminocarbonyl-phosphonates d4t inhibitors for reproducing human immunodeficiency virus
12/23/2004	WO2004111068A1 Colchicoside analogues
12/23/2004	WO2004111058A1 Heteroryl-fused pyrimidinyl compounds as anticancer agents
12/23/2004	WO2004111057A1 Thienopyrimidine derivatives as potassium channel inhibitors
12/23/2004	WO2004111047A2 Cycloalkanepyrrolopyridines as dp receptor antagonists
12/23/2004	WO2004111037A1 Cyclic tertiary amine compound
12/23/2004	WO2004111033A1 2-substitued 5, 6-diaryl-pyrazine derivatives as cb1 modulator.
12/23/2004	WO2004111028A1 Cyclic onium compounds and glucosidase inhibitors
12/23/2004	WO2004111027A1 The isoflavone derivatives of tectoridin, the preparation thereof and the anti-virus medicines containing the same as the effective constituents
12/23/2004	WO2004111024A1 Thiadiazoline derivative
12/23/2004	WO2004111023A1 Thiadiazoline-1-oxide derivative
12/23/2004	WO2004111015A1 Modulators of the glucocorticoid receptor and method
12/23/2004	WO2004111013A1 Hepatitis c virus inhibitors
12/23/2004	WO2004110998A1 Pyrrole compounds and uses thereof
12/23/2004	WO2004110993A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
12/23/2004	WO2004110992A2 Process for imidazo[4,5-c] pyridin-4-amines
12/23/2004	WO2004110986A1 Benzamide derivative or salt thereof
12/23/2004	WO2004110980A1 Sphingolipids' polyalkylamines conjugates
12/23/2004	WO2004110500A1 Radioactively labelled amino acid analogues, their preparation and use
12/23/2004	WO2004110499A1 Sphingolipids polyalkylamine conjugates for use in transfection
12/23/2004	WO2004110497A2 Mitomycin conjugates cleavable by thiols
12/23/2004	WO2004110496A1 Sphingoid polyalkylamine conjugates for vaccination
12/23/2004	WO2004110495A1 Compositions for oral administration of campothecin and its analogs
12/23/2004	WO2004110494A1 Compositions for treating infection in cattle and swine
12/23/2004	WO2004110492A2 Composition comprising triptans and nsaids
12/23/2004	WO2004110488A1 Drug for overcoming anticancer agent resistance and method of screening the same
12/23/2004	WO2004110473A1 Use of a polyene macrolide antifungal agent in combination with a glycopeptide antibacterial agent
12/23/2004	WO2004110468A1 Transdermal compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
12/23/2004	WO2004110463A1 Compositions for prevention and treatment of cold and influenza-like symptoms comprising chelated zinc
12/23/2004	WO2004110462A1 Pharmaceutical composition or health food having antioxidizing activity comprising polyphosphate as an effective ingredient
12/23/2004	WO2004110461A1 Treatment of symptoms associated with bacterial vaginosis
12/23/2004	WO2004110460A1 Formoterol and ciclesonide combination
12/23/2004	WO2004110459A1 Thiophenepyrimidinones as 17-beta-hydroxysteroid dehydrogenase inhibitors
12/23/2004	WO2004110458A1 Phenothiazine enantiomers as agents for the prevention of bone loss
12/23/2004	WO2004110457A1 Matrix metalloproteinases inhibitors for the stimulation and protection of bone marrow stem cells
12/23/2004	WO2004110456A1 Fcompositions of a cyclooxygenase-2 selective inhibitor, a xanthine compound and an alcohol for the treatment of ischemic mediated central nervous system disorders or injury
12/23/2004	WO2004110455A1 Combination comprising a cdk inhibitor and a topoisomerase i inhibitor for the treatment of cancer and other proliferative diseases
12/23/2004	WO2004110454A1 COMPOSITION FOR TREATMENT FOR OR PREVENTION OF DISEASE NECESSITATING ADMINISTRATION OF ADENOSINE A2a RECEPTOR AGONIST
12/23/2004	WO2004110453A1 Pyrimidine derivatives as cannabinoid receptor ligands
12/23/2004	WO2004110451A1 Combinations for opioid-based treatment of pain comprising 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives
12/23/2004	WO2004110450A1 Composition comprising a pulmonary surfactant and a pde5 inhibitor for the treatment of lung diseases
12/23/2004	WO2004110448A1 Medicinal composition containing benidipine hydrochloride
12/23/2004	WO2004110447A1 Use of tetrahydronaphtalene derivatives for treatment of gi disorders
12/23/2004	WO2004110446A1 Use of tetrahydronaphtalene derivatives for the treatment of ibs
12/23/2004	WO2004110445A1 Phentanyl-containing adhesive patch for application to oral-cavity mucosa
12/23/2004	WO2004110444A1 Neurocyte protective agent
12/23/2004	WO2004110443A1 Treatment for alzheimer's disease and related conditions
12/23/2004	WO2004110441A1 Pharmaceutical formulations comprising amoxicillin and clavulanate
12/23/2004	WO2004110440A1 Synergistic combinations including n-acylated 4-hydroxyphenylamine derivatives and caffeine
12/23/2004	WO2004110438A1 Agent for photodynamic diagnosis and therapy of oncological diseases
12/23/2004	WO2004110437A1 Asenapine for the treatment of schizophrenia in a patient with overweight or predisposition for overweight
12/23/2004	WO2004110433A1 Pyrrolidin-1, 2- dicarboxylic acid- 1- [(4- ethinyl- phenyl) - amid]- 2- [(phenyl)- amid] derivative as inhibitors of coagulation factor xa and viia for the treatment of thrombosis
12/23/2004	WO2004110431A1 Stable compositions of atorvastatin prepared with wet granulation
12/23/2004	WO2004110430A1 Use of substituted chromans or thiocromans for the treatment of fgd
12/23/2004	WO2004110429A1 Use of substituted chromans or thiocromans for the treatment of ibs
12/23/2004	WO2004110428A1 Anti-inflammatory analgesic adhesive patch
12/23/2004	WO2004110427A1 Preventing atrial fibrillation (af) with the use of statin drugs
12/23/2004	WO2004110426A1 Modulation of airway inflammation in patients with cystic fibrosis and related diseases
12/23/2004	WO2004110425A1 Use of sorbic aid for prevention of bacterial infections and as performance enhancer for animals
12/23/2004	WO2004110424A1 Method and pharmaceutical formulation for reducing stress-induced accelerated colonic transit in a mammal
12/23/2004	WO2004110423A1 Anesthetic composition for topical administration comprising lidocaine, prilocaine and tetracaine
12/23/2004	WO2004110422A1 Extended-release tablets of metformin
12/23/2004	WO2004110421A1 Use of 2-amino-1-3-propanediol derivatives for the manufacture of a medicament for the treatment of various types of pain
12/23/2004	WO2004110420A1 Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen

1 ... 4846 4847 4848 4849 4850 4851 4852 4853 4854 4855 4856 4857 4858 4859 4860 4861 4862 4863 4864 4865 4866 ... 7860